Predictive Value of MRD in Ph+ ALL Treated With Imatinib in the EsPhALL Study, Based on IG/TR and BCR/ABL1 Methodologies

Haematologica - Italy
doi 10.3324/haematol.2017.176917
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

BCR-ABL1-independent PI3Kinase Activation Causing Imatinib-Resistance

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2011English

BCR-ABL1 and Beyond

Pathology
Forensic MedicinePathology
2020English

BCR-ABL1 Mutations in Patients With Imatinib-Resistant Philadelphia Chromosome-Positive Leukemia by Use of the PCR-Invader Assay

Leukemia Research
Cancer ResearchOncologyHematology
2011English

Reactive Oxygen Species and Mitochondrial DNA Damage and Repair in BCR-ABL1 Cells Resistant to Imatinib

BioResearch Open Access
BiochemistryGeneticsMolecular Biology
2015English

In the Era of BCR-ABL1 Inhibitors, Are We Closing the Survival Gap Between Allogeneic Hematopoietic Cell Transplantation and Chemotherapy for Ph+ ALL in First Complete Remission?

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Clinical and Genetic Studies of ETV6/ABL1-positive Chronic Myeloid Leukaemia in Blast Crisis Treated With Imatinib Mesylate

British Journal of Haematology
Hematology
2003English

The Use of Imatinib Resistance Mutation Analysis to Direct Therapy in Philadelphia Chromosome/BCR-Abl1 Positive Chronic Myeloid Leukaemia Patients Failing Imatinib Treatment, in Patan Hospital, Nepal

British Journal of Haematology
Hematology
2017English

The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse Model

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2018English

Monitoring of Minimal Residual Disease (MRD) Is Useful to Predict Prognosis of Adult Patients With Ph-Negative ALL: Results of a Prospective Study (ALL MRD2002 Study)

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy